May 2010 Briefing - Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Self-Reported Peanut, Tree Nut Allergies in Children on the Rise
MONDAY, May 24 (HealthDay News) -- Although the number of adults allergic to peanuts, tree nuts and sesame seems to have remained relatively stable since 1997, the prevalence of self-reported peanut and tree nut allergies in children has climbed substantially, according to research published online May 12 in the Journal of Allergy and Clinical Immunology.
FDA Warns Consumers Against Swallowing Topical Benadryl
THURSDAY, May 13 (HealthDay News) -- The U.S. Food and Drug Administration has alerted consumers regarding potentially serious side effects associated with mistakenly swallowing Benadryl Extra Strength Itch Stopping Gel, an over-the-counter (OTC) product intended only for topical use.
New FDA Program Targets Misleading Drug Advertising
WEDNESDAY, May 12 (HealthDay News) -- The U.S. Food and Drug Administration has announced the launch of a new program to educate health care providers regarding their role in making certain that advertisements and promotions for prescription drugs are truthful and not misleading.
Children's and Infants' Liquid Medicines Recalled
MONDAY, May 3 (HealthDay News) -- McNeil Consumer Healthcare and the U.S. Food and Drug Administration have alerted health care professionals of the voluntary recall of various over-the-counter liquid products for children and infants, including Tylenol, Motrin, Zyrtec and Benadryl products, as some of them may not meet quality standards.